Vaccines Archive — Page 5 of 14
-
February 9, 2022
Vanderbilt and CDC research shows third vaccine dose key to preventing omicron hospitalization
Vanderbilt research shows that two doses of an mRNA COVID-19 vaccine result in lower effectiveness for preventing hospitalization for the omicron variant than previous variants. However, importantly, a third (“booster”) vaccine dose significantly improves protection against omicron hospitalization up to 86%. -
January 24, 2022
Vanderbilt recruiting children to study allergic responses to COVID-19 mRNA vaccines
Vanderbilt is conducting a clinical trial to determine risk and mechanisms of allergic reactions to COVID-19 Pfizer-BioNTech mRNA vaccine among children. -
January 20, 2022
Omicron evades some but not all monoclonal antibodies: study
A new study found that several, but not all, of the human monoclonal antibodies used clinically to prevent patients from becoming severely ill from COVID-19 may not be protective against the Omicron variant now sweeping across the United States. -
January 6, 2022
Grant boosts vaccine effectiveness research
-
December 28, 2021
Vanderbilt Kennedy Center produces videos to build vaccine confidence in disability community
-
December 24, 2021
Study of fully vaccinated patients with cancer who had breakthrough COVID-19 shows 13% mortality rate
New research finds that fully vaccinated patients with cancer who had breakthrough COVID-19 infections remained at high risk for hospitalization and death. -
December 23, 2021
Patient receives antibodies discovered at Vanderbilt to prevent COVID-19 illness
On Dec. 22, Caroline Davis of Nashville became the first patient at Vanderbilt University Medical Center to receive injections of a new antibody combination to protect her from COVID-19.